Journal Home
Search for

Volume 45, Issue 6, Pages 1142-1147 (June 2007)


View previous. 14 of 65 View next.

Aspirin resistance among long-term aspirin users after carotid endarterectomy and controls: Flow cytometric measurement of aspirin-induced platelet inhibition

Afshin Assadian, MDaCorresponding Author Informationemail address, Jaqueline Lax, MSb, Ursula Meixner-Loicht, MDa, Georg W. Hagmüller, MDa, Peter Michael Bayer, MDb, Wolfgang Hübl, MDb

Received 14 December 2006; accepted 24 January 2007.

Background

Numerous studies have indicated that some patient subpopulations do not respond to the antithrombotic effects of aspirin. The objective of this study was to evaluate aspirin-induced inhibition of platelet cyclooxygenase (COX) using a flow cytometric technique in long-term aspirin users after carotid endarterectomy (CEA) and controls with newly diagnosed carotid stenosis not taking aspirin and to compare these results with platelet function analyzer measurements.

Methods

The study included 86 patients with a history of CEA on long-term aspirin therapy (100 mg daily) and 29 age-matched patients with newly diagnosed carotid artery stenosis not taking aspirin. Platelet-rich plasma diluted with phosphate-buffered saline was incubated with arachidonic acid (ARA) at a final concentration of 80 μmol/L. After staining with phycoerythrin-labeled anti-P-selectin (CD62p) antibody, platelet CD62p-antigen expression was measured on a flow cytometer.

Results

Flow cytometric measurement of ARA-induced platelet activation showed an inhibition of ARA-induced platelet stimulation in all patients on aspirin therapy, whereas all but two controls (95%) showed expected platelet reactivity. In contrast, results of the platelet function analyzer measurements were normal in 16% of aspirin-treated patients.

Conclusions

Flow cytometric measurement of CD62p expression on platelets after incubation with ARA proved to be a practicable tool to monitor aspirin-induced inhibition of platelet COX. Results in patients on long-term low-dose aspirin therapy show that the inability of aspirin to inhibit platelet COX for both symptomatic and asymptomatic patients with high-grade internal carotid artery stenosis is a very rare event. So-called aspirin resistance detected quite frequently by platelet function analyzer measurement is most likely from COX-independent mechanisms.

a Department of General and Vascular Surgery, Wilhelminenspital Vienna, Vienna, Austria

b Department of Laboratory Medicine, Wilhelminenspital Vienna, Vienna, Austria.

Corresponding Author InformationReprint requests: Afshin Assadian, MD, Department of General and Vascular Surgery, Wilhelminenspital Vienna, Montleartstr 37, A-1160 Vienna, Austria.

 Competition of interest: none.

PII: S0741-5214(07)00229-7

doi:10.1016/j.jvs.2007.01.064


View previous. 14 of 65 View next.